Description

4-o-(2,6-Diamino-2,4,6-Trideoxy-α-D-Xylo-Hexopyranosyl)-5-o-β-D-Ribofuranosyl-n-[(S)-4-Amino-2-Hydroxybutyryl]-2-Deoxy-D-Streptamine is a complex semisynthetic aminoglycoside antibiotic derivative, representing a sophisticated chemical entity for advanced research and development. This compound is of significant interest for its potential role in studying antibiotic mechanisms, resistance, and the synthesis of novel therapeutic agents. It is primarily required by pharmaceutical R&D laboratories, biotechnology firms, and academic institutions engaged in antimicrobial research, medicinal chemistry, and the development of next-generation infection treatments.

Application

• Pharmaceutical Reference Standard: Serves as a high-purity chemical reference material (CRM) for quality control and analytical method development in antibiotic production.
• Medicinal Chemistry Research: Used as a key intermediate or lead compound in the synthesis and structure-activity relationship (SAR) studies of novel aminoglycoside antibiotics.
• Biochemical Studies: Employed in research to investigate bacterial ribosome targeting, mechanisms of antibiotic action, and pathways of microbial resistance.
• API Development: Acts as a critical starting material or advanced intermediate in the process development and scale-up of active pharmaceutical ingredients (APIs).
• Academic Research: Utilized in university and institutional labs for fundamental studies in organic synthesis, carbohydrate chemistry, and microbiology.

Basic Information

Product Name	4-o-(2,6-Diamino-2,4,6-Trideoxy-α-D-Xylo-Hexopyranosyl)-5-o-β-D-Ribofuranosyl-n-[(S)-4-Amino-2-Hydroxybutyryl]-2-Deoxy-D-Streptamine
CAS No.	53185-10-7
Molecular Formula	C23H44N6O12
Molecular Weight	596.63 g/mol
Synonyms	4-O-(2,6-Diamino-2,4,6-trideoxy-α-D-xylo-hexopyranosyl)-5-O-β-D-ribofuranosyl-N-[(1S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine; 4-O-(2,6-Diamino-2,4,6-trideoxy-α-D-xylo-hexopyranosyl)-5-O-β-D-ribofuranosyl-N-[(S)-4-amino-2-hydroxybutyryl]-2-deoxy-D-streptamine; Antibiotic XK 62-2; 4-O-(2,6-Diamino-2,4,6-trideoxy-α-D-xylo-hexopyranosyl)-5-O-β-D-ribofuranosyl-N-[(S)-4-amino-2-hydroxybutanoyl]-2-deoxy-D-streptamine; A derivative of Butirosin; Semisynthetic Aminoglycoside
EINECS	Contact for details

Quality Control

Our 4-o-(2,6-Diamino-2,4,6-Trideoxy-α-D-Xylo-Hexopyranosyl)-5-o-β-D-Ribofuranosyl-n-[(S)-4-Amino-2-Hydroxybutyryl]-2-Deoxy-D-Streptamine is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, spectroscopic identification (IR, NMR), and specific tests for related substances. We provide a detailed Certificate of Analysis (COA) with each shipment, ensuring traceability and compliance with your research or development specifications. Our quality commitment supports applications requiring high-purity reference standards and pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Single Maximum Unknown Impurity	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.